A systematic literature review suggests that GlcN has no effect on fasting blood glucose levels, glucose metabolism, or insulin sensitivity at any oral dose level in healthy subjects, individuals with diabetes, or those with impaired glucose tolerance [61]. The gene discussed is INS; the disease is diabetes mellitus.